Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trial of Accelerated Adjuvant Chemotherapy With Capecitabine in Early Breast Cancer.

Trial Profile

Trial of Accelerated Adjuvant Chemotherapy With Capecitabine in Early Breast Cancer.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 17 Aug 2018

At a glance

  • Drugs Capecitabine (Primary) ; Epirubicin (Primary) ; Cyclophosphamide; Cyclophosphamide; Fluorouracil; Methotrexate; Pegfilgrastim
  • Indications Early breast cancer; Male breast cancer
  • Focus Therapeutic Use
  • Acronyms TACT2
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 19 Mar 2014 Efficacy results on capecitabine vs CMF presented at the 9th European Breast Cancer Conference.
    • 19 Mar 2014 Accruel to date is 97% according to UK Clinical Research Network
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top